Table: Oncolys Biopharma - Q1 parent results

Oncolys Biopharma

07/05/2021 07:00

May 7 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2021        Mar 31, 2020     Dec 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            62 mln              70 mln                     
                 (-10.9 pct)         (+45.2 pct)                  
  Operating     loss 349 mln        loss 287 mln                  
  Recurring     loss 349 mln        loss 285 mln                  
  Net           loss 350 mln        loss 286 mln                  
  EPS          loss 22.36 yen      loss 19.96 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T